From Systems to Synthetic Biology:

quantitative understandig for rational engineering

 
Pulmobiotics1.gif

Building on over 10 years of research funded with over 14m € by Spanish and EU grant agencies (details here), we have developed a proprietary microbial engineering and synthetic biology toolbox that underpins a novel live biotherapeutics platform.

 A novel live biotherapeutic platform for treating human lung diseases

 Our platform is based on attenuated lung bacteria able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner. It allows engineering of multiple genetic circuits to specifically target and deliver payloads.

Pulmobiotics_pulmon.png
Vaccines.gif

 Infectious diseases

TISSUE REGENERATION
Tissue.gif

 Chronic obstructive

pulmonary disease

 Infectious diseases

 Cystic Fibrosis

 Infectious diseases

IMMUNE SYSTEM MODULATION
Immune-System.gif

 Asthma

 Lung Cancer

 

 Pulmobiotics       |       Platform       |      Respiratory diseases     |      Partners       |       Team        |     Contact

 Pulmobiotics

 

 A novel live biotherapeutic platform

for treating human lung diseases.